MSEX:LSE:LSE-Lyxor UCITS Euro Stoxx 50 Dailly GBP (GBX)

ETF | Others |

Last Closing

USD 23255

Change

0.00 (0.00)%

Market Cap

N/A

Volume

446.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+1.22 (+0.60%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.17 (+0.89%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.33%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+0.43 (+0.31%)

USD 618.20B
0R1G:LSE Home Depot Inc.

+187.08 (+104.77%)

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

+0.32 (+1.00%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.20%)

USD 266.08B
0QZO:LSE 0QZO

-0.28 (-0.25%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.40 (-0.96%)

USD 202.26B
0R24:LSE Intel Corp.

-0.10 (-0.48%)

USD 196.14B

ETFs Containing MSEX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.67% 87% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.67% 86% B+ 78% C+
Trailing 12 Months  
Capital Gain 12.71% 77% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.71% 75% C 72% C
Trailing 5 Years  
Capital Gain 110.34% 88% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 110.34% 87% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 14.37% 75% C 77% C+
Dividend Return 14.37% 75% C 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.96% 53% F 71% C-
Risk Adjusted Return 110.82% 94% A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike